Prace polskich autorów przedstawione na 19. Światowej Konferencji Raka Płuca - WCLC 2018

26 września 2018

Prace polskich autorów przedstawione na 19. Światowej Konferencji Raka Płuca - WCLC 2018, odbywającej się w dniach 23-26 września 2018 r. w Toronto:

  • Dziadziuszko R. MS14.04 - "IO - New Standards in Stage III NSCLC”.
  • Jassem J. MS24.03 - "The Importance of Physician Involvement in Tobacco Control”.
  • Wrona A. GR02.01 - "Case 1: Single Zone N2 (No Pneumonectomy Necessary)”.
  • Chmielowska E. i wsp. P3.01-17 - "Long Survivors with Advanced Lung Cancer - Efficacy and Tolerability of Nivolumab”.
  • Chorostowska-Wynimko J. i wsp. P2.11-20 - "Lung EpiCheck TM - Results of the Training and Test Sets of a Methylation-Based Blood Test for Early Detection of Lung Cancer”.
  • Chorostowska-Wynimko J. i wsp. P2.13-14 - "The Clinical Usefulness of Liquid Biopsy for Detection and Dynamic Monitoring of EGFR T790M in NSCLC Patients on EGFR-TKI Therapy”.
  • Chorostowska-Wynimko J. i wsp. P2.13-31 - "p.(Leu747Pro) Mutation Leads to Misdiagnosis in EGFR Mutation Assessment – Analysis in a Cohort of 1841 Polish NSCLC Patients”.
  • Doboszyńska A. i wsp. P2.10-11 A. i wsp. - "Impact of Smoking on Multiple Primary Cancers Survival – A Retrospective Analysis”.
  • Gil T. i wsp. P2.17-11 T. i wsp. - "Impact of Quantitatively Assessed Emphysema on Chest Tube Drainage After Lobectomy for Non-Small Cell Lung Cancer”.
  • Gil T. i wsp. P3.01-29 T. i wsp. - "St.Iv Lung Adenocarcinoma Treated by First-Line EGFR–Tyrosine Kinase Inhibitors-Survival, EGFR Mutation, Histologic Subtype”.
  • Kowalewski J. i wsp. P1.16-22 - "Meta-Analysis of Stereotactic Ablative Radiotherapy Versus Surgery for Early Stage Lung Cancer”.
  • Kowalewski J. i wsp. P1.16-38 - "Meta-Analysis of Unplanned Readmissions Following Thoracoscopic Versus Open Lung Cancer Resection”.
  • Krawczyk P. i wsp. P1.11-03 - "MicroRNA with Ability to Reciprocal Regulation of Dicer and Drosha – Plasma Expression Status and Diagnostic Value in Non-Small Cell Lung Cancer”.
  • Krawczyk P. i wsp. P2.04-05 - Correlation Between PD-L1 Gene Promoter Polymorphisms and Expression of PD-L1 mRNA and Protein in NSCLC Patients”.
  • Marjański T. i wsp. P3.16-31 - "Younger Patients Operated for Lung Cancer Have Better Overall Survival”.
  • Ostrowski M. i wsp. P2.11-16 - "Comparison of Two Lung Cancer Screening Programs in One Medical Center - Does Experience of the Screening Team and Indications Affect the Results?”
  • Pieróg J. i wsp. P1.05-13 – "The Demonstration of the Possibility of the Pleura Cryo Biopsy – A Preliminary Report”.
  • Rzyman W. i wsp. P2.01-81 - "Treatment of Superior Sulcus Tumor: A Twelve-Year Single-Center Experience”.
  • Szczęsna M. i wsp. P1.16-55 - "Surgical Treatment for Lung Cancer. Subaortic (Para-Aortic) Lymph Nodes Involvement - N1 or N2 Disease?”
  • Wojas-Krawczyk K. i wsp. P1.13-14 - "The Molecular Landscape of Lung Adenocarcinomas with Activating EGFR Gene Mutations Determined by Targeted-Sequencing”.
  • Wojas-Krawczyk K. i wsp. P3.13-08 - "Assessment of EGFR Gene Mutations In cf-DNA in Monitoring of Response to EGFR TKIs in Patients with Lung Adenocarcinoma”.